NCT00421694View on ClinicalTrials.gov

Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

Not specified

Conditions

Prostate Cancer

Interventions

DRUG

Bicalutamide

Trial Locations (1)

67100

University of L'Aquila, L’Aquila

All Listed Sponsors

lead

University of L'Aquila

OTHER